ABSTRACT
BACKGROUND: Little is known about postoperative opioid prescribing patterns among dermatologic surgeons. OBJECTIVE: To better understand postoperative opioid prescribing patterns among dermatologic surgeons in the United States. MATERIALS AND METHODS: Two-part analysis consisting of a retrospective chart review of 233 dermatologic surgery patients at a single institution and an e-mail survey of American Society for Dermatologic Surgery (ASDS) members. RESULTS: (1) Retrospective review: 35% (82/233) of the patients received an opioid prescription. Larger defect size, repair of the defect, perioral and nasal site, and surgeon A or B performing surgery predicted opioid prescription. (2) E-mail survey: 556 ASDS members practicing within the United States responded. Sixty-four percent (357/556) reported prescribing opioids after ≤10% of cases. Surgeons younger than 55 years old, male surgeons, and surgeons in the southern and western United States were more likely to prescribe opioids after >10% of cases. Seventy-six percent (397/520) believed patients used ≤50% of the opioid pills prescribed. CONCLUSION: The retrospective review suggests that opioid prescribing is predicted by characteristics of the surgery (i.e., size, defect repair type, and anatomic location) and characteristics of the surgeon (i.e., age, sex, and practice location) with significant heterogeneity in prescribing habits. The national survey results raise the possibility that patients might not take all prescribed opioid pills after dermatologic surgery. Further investigation is warranted to determine how patients are actually using prescription pain pills to balance pain control with patient safety.
Subject(s)
Analgesics, Opioid/therapeutic use , Facial Neoplasms/surgery , Mohs Surgery/adverse effects , Pain, Postoperative/drug therapy , Practice Patterns, Physicians'/statistics & numerical data , Skin Neoplasms/surgery , Acetaminophen/therapeutic use , Age Factors , Aged , Aged, 80 and over , Carcinoma, Basal Cell/surgery , Carcinoma, Squamous Cell/surgery , Codeine/therapeutic use , Drug Combinations , Female , Health Care Surveys , Humans , Hydrocodone/therapeutic use , Male , Melanoma/surgery , Middle Aged , Oxycodone/therapeutic use , Pain, Postoperative/etiology , Professional Practice Location , Retrospective Studies , Sex Factors , Societies, Medical , United StatesABSTRACT
OBJECTIVE: To better understand postoperative opioid use after dermatologic surgery. DESIGN: Prospective observational study. SETTING: Academic dermatology department. PATIENTS: The study included 212 adults (1) who were undergoing a single skin excision (including Mohs micrographic surgery), (2) who consented to participate,and (3) who were able to be reached by telephone on postoperative day 3 or 4. Patients who did not meet these criteria and those referred to another physician for further surgical treatment or repair were excluded. MAIN OUTCOME MEASURES: The study examined(1) the incidence of opioid prescription after dermatologic surgery, (2) the percentage of prescribed opioid pain medications used in the postoperative period, and (3) patient and surgical characteristics associated with opioid pain medication prescription and use. RESULTS: Opioids were prescribed to 72 of the 212 patients(34%). Twenty-five of the 72 patients (35%) who were prescribed opioids did not use them. Forty-nine of 57 patients (86%) who filled an opioid prescription had leftover pills, and 26 of the 49 patients (53%) planned to keep them. Only maximum pain score was significantly associated with opioid use. CONCLUSIONS: Opioids were over prescribed after dermatologic surgery. Patients who had left over opioids did not dispose of them properly, which could lead to potential misuse and abuse.